SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 423.51 |
| Enterprise Value ($M) | 391.66 |
| Book Value ($M) | 172.80 |
| Book Value / Share | 4.00 |
| Price / Book | 2.45 |
| NCAV ($M) | 164.24 |
| NCAV / Share | 3.80 |
| Price / NCAV | 2.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.79 |
| Return on Assets (ROA) | -1.02 |
| Return on Equity (ROE) | -1.24 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.55 |
| Current Ratio | 8.55 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 191.63 |
| Assets | 200.20 |
| Liabilities | 27.40 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Vestal Point Capital, LP | 9.30 | ||
| 13G/A | Suvretta Capital Management, Llc | 9.99 | 61.29 | |
| 13G/A | Tang Capital Management Llc | 9.99 | ||
| 13G | Capital World Investors | 7.80 | ||
| 13G/A | Adage Capital Management, L.P. | 3.29 | ||
| 13G/A | Vanguard Group Inc | 4.97 | 0.00 | |
| 13D/A | Frazier Life Sciences Public Fund, L.P. | 10.00 | 32.54 | |
| 13D/A | TCG Crossover GP I, LLC | 3.20 | -50.17 | |
| 13G | Adage Capital Partners Gp, L.l.c. | 6.87 | ||
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 14.00 | 35.01 | |
| 13G/A | Tang Capital Partners Lp | 9.96 | 7.63 | |
| 13G | Saturn V Capital Management LLC | 4.10 | ||
| 13G/A | Fmr Llc | 0.15 | -96.11 | |
| 13G | BlackRock, Inc. | 6.50 | 42.58 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 211,786 | 723,521 | 29.27 | |
| 88,885 | 469,509 | 18.93 | |
| 68,339 | 240,749 | 28.39 | |
| 43,689 | 197,385 | 22.13 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IVVD – Invivyd, Inc. | IXHL – Incannex Healthcare Inc. |
| JANX – Janux Therapeutics, Inc. | KLTO – Klotho Neurosciences, Inc. |
| KOD – Kodiak Sciences Inc. |
Financial data and stock pages provided by
Fintel.io